| 12503475 |
Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists |
Karen Theresa Gibson, Matthew SPENDIFF, Paul Humphries, Sarah Joanne Bucknell, Wojciech ZAWODNY +1 more |
2025-12-23 |
|
| 8383660 |
Dibenzyl amine compounds and derivatives |
George Chang, Ravi Shanker Garigipati, David A. Perry |
2013-02-26 |
$623,161,000 |
| 7919506 |
Dibenzyl amine compounds and derivatives |
George Chang, Ravi Shanker Garigipati, David A. Perry, Dongxiang Zeng |
2011-04-05 |
$321,745,000 |
| 7799823 |
Androgen modulators |
Stephen Douglas Barrett, Victor Fedij, Lain-Yen Hu, Donna Iula, Raj K. Raheja +2 more |
2010-09-21 |
|
| 7674819 |
Androgen modulators |
Stephen Douglas Barrett, Victor Fedij, Lain-Yen Hu, Donna Iula, Raj K. Raheja +2 more |
2010-03-09 |
|
| 7670613 |
Androgen modulators |
Lain-Yen Hu, Daniel Y. Du, Yvonne Dorothy Smith, Huangshu Lei, William Harter +3 more |
2010-03-02 |
$207,756,000 |
| 7576128 |
Androgen receptor modulators |
Lain-Yen Hu, Huangshu Lei, Daniel Y. Du |
2009-08-18 |
$206,216,000 |
| 7507732 |
Cyclopentapyridine and tetrahydroquinoline derivatives |
Kevin Liu, Hou Chen, Steven Blair Coffey |
2009-03-24 |
$217,987,000 |
| 7507860 |
Androgen modulators |
Lain-Yen Hu, Huangshu Lei, Daniel Y. Du, Yvonne Dorothy Smith, Victor Fedij |
2009-03-24 |
$217,987,000 |
| 7473711 |
Androgen modulators |
Lain-Yen Hu, Huangshu Lei, Daniel Y. Du |
2009-01-06 |
$204,330,000 |
| 7442702 |
Prostaglandin agonists |
Kimberly O. Cameron, Robert L. Rosati |
2008-10-28 |
$154,383,000 |
| 7414071 |
Methods of treatment with selective EP4 receptor agonists |
Kimberly O. Cameron, Delvin R. Knight, Jr. |
2008-08-19 |
$233,119,000 |
| 7192979 |
EP4 receptor selective agonist in the treatment of osteoporosis |
Kimberly O. Cameron |
2007-03-20 |
$254,717,000 |
| 6998423 |
Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
Kimberly O. Cameron, Hua Zhu Ke, Robert L. Rosati, David Thompson |
2006-02-14 |
$991,144,000 |
| 6953791 |
Dipeptide derivatives |
Philip A. Carpino, David A. Griffith |
2005-10-11 |
$495,540,000 |
| 6951850 |
Dipeptide derivatives |
Philip A. Carpino, David A. Griffith |
2005-10-04 |
$168,640,000 |
| 6924280 |
Dipeptide derivatives |
Philip A. Carpino, David A. Griffith |
2005-08-02 |
$211,477,000 |
| 6867202 |
Treatment of insulin resistance |
Philip A. Carpino, Charles Kwok-Fung Chiu, Lydia Pan, Judith Treadway, Michael P. Zawistoski |
2005-03-15 |
$262,568,000 |
| 6852863 |
Metabolites of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid |
Kimberly O. Cameron, Kim A. Johnson, Chandra Agarwal Prakash |
2005-02-08 |
$111,158,000 |
| 6747054 |
EP4 receptor selective agonists in the treatment of osteoporosis |
Kimberly O. Cameron |
2004-06-08 |
$562,549,000 |
| RE38524 |
Dipeptide derivatives as growth hormone secretagogues |
Philip A. Carpino, David A. Griffith |
2004-06-01 |
|
| 6737437 |
EP4 receptor selective agonists in the treatment of osteoporosis |
Kimberly O. Cameron, HuaZhu Ke, David Thompson |
2004-05-18 |
$546,360,000 |
| 6649657 |
Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
Kimberly O. Cameron, Hua Zhu Ke, Robert L. Rosati, David Thompson |
2003-11-18 |
$153,763,000 |
| 6642266 |
EP4 receptor selective agonists in the treatment of osteoporosis |
Kimberly O. Cameron, HuaZhu Ke, David Thompson |
2003-11-04 |
$235,509,000 |
| 6630487 |
Treatment of insulin resistance with growth hormone secretagogues |
Philip A. Carpino, Charles Kwok-Fung Chiu, Lydia Pan, Judith Treadway, Michael P. Zawistoski |
2003-10-07 |
$307,545,000 |
